ATLASATLAS fair value
IDR 1,151
Below fair value · 38% discount
Range: IDR 814–IDR 1,628Fair valuePrice
Kalbe Farma (KLBF.JK)
Kalbe Farma stock price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - General · Indonesia Stock Exchange · Indonesia
IDR 710.00▼ -2.07%
Prices as of Oct 27, 2026 · IDR
Chance of rising in 1 month
49%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Kalbe Farma in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Kalbe Farma
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates Kalbe Farma's fair value at about IDR 1,151 per share (reasonable range: IDR 814.47 to IDR 1,628). At IDR 710.00, the stock trades 38% below it.
It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is medium. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Kalbe Farma a 49% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between IDR 654.58 and IDR 765.79; in 9 out of 10, between IDR 569.58 and IDR 880.07. Estimated annual volatility is 48%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- IDR 35.9T
- Market cap (USD)
- $2.0B
- P/E ratio
- 8.2
- Dividend yield
- 2.88%
- 52-week high
- IDR 1,340
- 52-week low
- IDR 630.00
- Revenue (12 months)
- IDR 37.7T
- Gross margin
- 37.4%
- Operating margin
- 11.9%
- Net margin
- 9.6%
- Beta
- -0.04
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Kalbe Farma sits below fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks KLBF.JK has traded between IDR 630.00 and IDR 1,340. Today it is 47.0% below that high and 13% above its low.
On the business: net margin is 9.6%; it trades at 8.2 times earnings.
Its beta is -0.04: it tends to move less than the market.
About the company
, together with its subsidiaries, engages in the development, manufacture, and trading of pharmaceutical products in Indonesia. It operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments.
Want to see everything about Kalbe Farma?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is Kalbe Farma (KLBF.JK) fair value?
About IDR 1,151 per share according to ATLAS (reasonable range: IDR 814.47 to IDR 1,628). With the stock at IDR 710.00, it is 38% below it.
What is the chance KLBF.JK goes up next month?
49%: close to a coin flip. In half of the simulated outcomes, KLBF.JK ends the month between IDR 654.58 and IDR 765.79.
How big is Kalbe Farma and what is its P/E ratio?
Kalbe Farma's market capitalization is IDR 35.9T. Its price-to-earnings (P/E) ratio is 8.2: you pay IDR 8.19 for each IDR 1.00 of yearly earnings.
Does Kalbe Farma pay a dividend?
Yes. KLBF.JK's current dividend yield is 2.88% at today's price (IDR 710.00).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer